Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
Go back to Glaukos Submits New Drug Application to U.S. FDA for Epioxa™| (NYSE: GKOS) | Delayed: 189.55 +5.40 (2.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $184.15 | 52 Week High | $39.82 | |||
| Open | $186.00 | 52 Week Low | $14.25 | |||
| Day High | $190.06 | P/E | N/A | |||
| Day Low | $185.96 | EPS | $0.00 | |||
| Volume | 505,393 | |||||
